AKT1 and triple-negative breast carcinoma: Zhou et al. reported that Linc00665 can encode a micropeptide cip2a-bp and inhibit PI3K/Akt/NF-κB pathway in triple negative breast cancer, thus inhibiting the invasion and metastasis of triple negative breast cancer (30).